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Cancer is a new epidemic in modern society.1,2 Whereas 
advances in biomedicine have increased cancer patients’ 
survival over recent decades, some individuals receiving 
cancer treatment experience significant adverse effects dur-
ing treatment. In addition to the adverse effects caused by 
cancer treatment, many people diagnosed with cancer suffer 
from anxiety, depression, and fear of recurrence.3,4 Thus, a 
high proportion of patients use complementary and alterna-
tive medicine (CAM), including acupuncture to manage 
their physical and psychological symptoms.5,6
Acupuncture has become a popular therapy to manage 
adverse effects during cancer treatment in recent years.7,8 
Emerging evidence from clinical trials has shown that acu-
puncture can alleviate symptoms of adverse effects during 
and post–cancer treatment. Several randomized controlled 
trials (RCTs) have evaluated acupuncture in the manage-
ment of adverse effects and reported beneficial impacts on 
depression,9 chemotherapy-induced nausea and vomiting,10 
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Abstract
Background. Guidelines surrounding optimum needle retention duration in acupuncture have not been established, despite 
a growing evidence base for acupuncture over recent decades. This retrospective study explored the effect of varying 
acupuncture needle retention durations in cancer patients. Method. Patients received either 2 (n = 35), 10 (n = 53), or 20 
minutes (n = 54) of acupuncture once a week for 6 weeks. Outcomes of anxiety and depression, stress, fatigue, and quality 
of life (QOL), with the Hospital Anxiety and Depression Scale, Perceived Stress Scale, Functional Assessment of Cancer 
Therapy–Fatigue, and European Organization for Research and Treatment of Cancer Quality of Life, were measured at 
baseline and at 6 weeks following the intervention. Results. The mean age of participants was 58 years (n = 152). The 
majority were female, diagnosed with breast cancer. Depression, stress, fatigue, and QOL were significantly improved in all 
3 groups at 6 weeks postintervention. No significant differences in all outcomes were found between the 3 groups (≤2 vs 10 
minutes vs 20 minutes). There were no differences with the satisfaction of the acupuncture services and perceived efficacy 
of acupuncture among the 3 groups. More than 95% of participants indicated that they would recommend acupuncture to 
other cancer patients, friends, and their family members. Conclusion. The efficacy of acupuncture may not only depend on 
needle retention duration, but may also be associated with multiple factors. Considering the limitations of this study design, 
robust randomized controlled studies are warranted to confirm the findings.
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chemotherapy-related neutropenia,11 and chemotherapy-
related hot flushes.12,13 Studies have also demonstrated that 
acupuncture can reduce fatigue,14 joint pain and stiff-
ness,15,16 and radiation-induced xerostomia11 and enhance 
overall well-being.17
Although several previous studies have demonstrated 
the value of acupuncture in cancer care, few studies have 
examined the relationship between dosage (needle retention 
duration, frequency, and total acupuncture dose) and clini-
cal outcomes.18 Two classical textbooks on acupuncture 
described needle retention durations as brief as 3 exhala-
tions19 and 6 exhalations20 for certain acupuncture points. 
Several studies conducted for pain management have dem-
onstrated that the acupuncture intervention induces an anal-
gesic effect irrespective of dose delivered.21 In contrast, 1 
observational study reported that the pain threshold 
increased with persistent needle stimulation and induced an 
analgesic effect between 30 and 40 minutes.22 With the 
dearth of standard acupuncture needle retention duration 
guidelines, trials have often used varying lengths (median 
of 30 minutes; range from 15 to 60 minutes).23
To date, acupuncture needle retention duration has not 
received great attention in clinical practice because of the 
philosophical basis of acupuncture. Generally, in acupunc-
ture, as with other CAM therapies, a greater weight is 
placed on personalized treatment methods based on indi-
vidual symptoms rather than a unified standard treatment. 
Furthermore, standardized, evidence-based acupuncture 
practice guidelines in relation to needle retention duration 
have yet to be established. In recognition of this gap, this 
study evaluated the effects of needle retention duration on 
clinical outcomes during systemic and radiation cancer 
treatment. We hypothesized that acupuncture needle reten-
tion duration is associated with the effect of acupuncture on 
clinical outcomes (anxiety, depression, stress, fatigue, and 




The medical records and the data collected to evaluate acu-
puncture services in the Northern Sydney Cancer Centre 
(NSCC) of the Royal North Shore Hospital (RNSH) were 
reviewed. Six sessions of acupuncture treatment were 
offered to patients free of charge at NSCC between June 
2014 and May 2016. Eligibility criteria to receive acupunc-
ture service were diagnosis of cancer (at any stage), age 18 
years or older, completion of or current treatment with sur-
gery, chemotherapy and/or targeted therapies and/or radio-
therapy or hormone therapy, and the ability to complete the 
questionnaire. Exclusion criteria included previous use of 
acupuncture during cancer treatment in the past 6 weeks, 
severe coagulopathy or bleeding disorder or dermatological 
disease within the acupuncture area, active infection and 
needle phobia rendering patient unable to receive acupunc-
ture, and inability to understand the nature of the study suf-
ficiently to allow completion of all study assessments.
Procedure
Patients were given information about the availability of 
acupuncture services by oncologists, care coordinators, 
nurses, and receptionists during their hospital visit. If 
patients were interested in receiving acupuncture, they were 
advised to make a booking for acupuncture treatment at 
reception.
Patients received a total of 6 sessions of acupuncture 
once a week over 6 weeks. The acupuncturist provided dif-
ferent acupuncture needle retention durations in the 3 
groups (needle retention duration for first, second, and third 
groups were 20 minutes after 10 minutes of consultation, 10 
minutes plus 10 minutes bedrest after 10 minutes of consul-
tation, 2 minutes plus 18 minutes of bedrest after 10 min-
utes of consultation, respectively); the total acupuncture 
intervention period was identical in all 3 groups. During the 
period of August 2014 to September 2015, patients were 
allocated to either group 1 or group 2 based on their first 
acupuncture appointment; 8 patients were booked for each 
day. In the patient’s booking list, odd numbers (1, 3, 5, and 
7) and even numbers (2, 4, 6, and 8) were assigned to groups 
1 and 2, respectively. Patients who received acupuncture 
during the period of October 2015 to March 2016 were allo-
cated to group 3. Patients were given the questionnaire by 
receptionists prior to the acupuncture consultation and 6 
weeks after completion of acupuncture treatment.
The preintervention questionnaire consisted of demo-
graphic information (gender, age, ethnicity, education, 
income, occupation, cancer diagnosis, extent of disease, 
and medical treatment received as well as major reasons 
that patients were considering having acupuncture) and 
anxiety, depression, stress, fatigue, and quality-of-life ques-
tionnaires. The postintervention questionnaire asked about 
the change of outcomes (anxiety, depression, stress, fatigue, 
and QOL) and included additional information to evaluate 
the acupuncture services (perceived efficacy and adverse 
effects of acupuncture, and satisfaction with acupuncture 
services). Ethics approval was obtained from the Human 
Research Ethics Committee of the RNSH.
Study Design and Outcomes
This was a retrospective exploratory pilot study. Data col-
lected to evaluate acupuncture services from June 2014 to 
May 2016 were analyzed. The effects of acupuncture on 
anxiety and depression, stress, fatigue, and QOL were mea-
sured with validated reported outcome instrument tools: the 
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Hospital Anxiety and Depression Scale (HADS), Perceived 
Stress Scale (PSS), Functional Assessment of Cancer 
Therapy Fatigue (FACT-Fatigue), and the European 
Organization for Research and Treatment of Cancer Quality 
of Life (EORTC QLQ-C30). In addition, single items of 
EORTC QLQ-C30 were applied to assess individual symp-
toms. The HADS contains the Anxiety and Depression sub-
scales.24 HADS was found to perform well in assessing the 
symptom severity of anxiety disorders and depression in 
both somatic, psychiatric, and primary care patients and in 
the general population. The PSS is commonly used in health 
and behavioral health contexts for examining patient-
reported stress experiences and psychoneurological 
responses.25 Cancer-related fatigue is generally assessed by 
the FACT-Fatigue.26 The EORTC QLQ-C30 is a question-
naire developed by the European Organization for Research 
and Treatment of Cancer to assess the QOL of cancer 
patients. This 30-item instrument has 5 functional scales 
(physical, role, cognitive, emotional, and social), 3 symptom 
scales (fatigue, pain, and nausea and vomiting), a global 
health and QOL scale and a number of single items assessing 
additional symptoms commonly reported by cancer patients 
(dyspnea, loss of appetite, insomnia, constipation, and diar-
rhea), and perceived financial impact of the disease. 
Questions 1 to 28 have 4-point response scales—namely, 
“Not at all,” “A little,” “Quite a bit,” and “Very much.” 
Questions 29 and 30 record global health status on a 7-point 
response scale (EORTC QOL-C30 Scoring Manual, 2001).27
Intervention
Patients received individualized acupuncture treatments 
based on their main complaint and ongoing cancer treatment. 
They were allowed to take their usual medication prescribed 
by their oncologists and general practitioner as needed and to 
include other CAM while they received acupuncture treat-
ment. During the consultation, the acupuncture practitioner 
evaluated patients’ clinical symptoms. Participants in all 3 
groups received bilateral perpendicular insertion of sterile 
disposable needles (Seirin J-type made in Japan, gauge and 
size 0.12 × 15 mm2) at various acupuncture points. The nee-
dling technique included twirling, thrusting, and lifting. The 
designation of acupuncture points adhered to the first edition 
of the Standard Acupuncture Nomenclature.28 Acupuncture 
was administered by a qualified acupuncture practitioner 
(BO), who had more than 15 years of acupuncture experi-
ence, was registered by the Chinese Medicine Board of 
Australia (CMBA), and had received accreditation from the 
RNSH and oncology acupuncture training.
Data Analysis
Descriptive statistics were used to characterize the demo-
graphic profile of patients among 3 groups. The outcomes 
measured by the HADS, PSS, FACT-F, and EORTC QLQ-
C30 at 2 time points (baseline and week 6) were analyzed. 
Because the outcomes generally had skewed distributions, 
we used nonparametric tests to analyze change over time 
and difference between groups. The Wilcoxon test was used 
to compare preintervention with postintervention data on 
the combined sample. For group comparisons, we calcu-
lated pre-post intervention change scores and first con-
ducted Kruskal-Wallis tests to determine whether there 
were overall group differences, followed by Mann-Whitney 
U-tests on each pair of groups (ie, 2 vs 10 minutes, 2 vs 20 
minutes, 10 vs 20 minutes). We used this strategy rather 
than a single Kruskal-Wallis test to examine specific group 
comparisons rather than overall differences between groups. 
All analyses were conducted using SPSS v22.
Results
Demographic Characteristics of Participants
A total of 142 patients received either 2 (n = 35), 10 (n = 
53), or 20 minutes (n = 54) of acupuncture treatment once a 
week for 6 weeks. The demographic characteristics of the 
participants are presented in Table 1. A χ2 analysis shows 
that there were no significant differences in age, gender, 
ethnicity, education level, income, occupation, cancer diag-
nosis, and duration of cancer diagnosis among the 3 groups.
Main Reasons for Considering Acupuncture Use
The most common reasons that participants gave for con-
sidering acupuncture use were fatigue, pain relief, difficulty 
sleeping, and neuropathy symptoms (Table 2).
Outcome Measurement
There were significant improvements from preintervention 
to postintervention for depression (P < .001), stress (P < 
.001), fatigue (P < .001), and QOL (P < .001) 6 weeks pos-
tintervention but no significant effects on anxiety (P = 
.072). There were no overall significant differences in anxi-
ety, depression, stress, fatigue, and QOL between the 3 
groups postintervention (Table 3). Subgroup analyses were 
conducted to compare differences between each group (2 vs 
10 minutes, 2 vs 20 minutes, and 10 vs 20 minutes). In a 
subgroup analysis comparing the 2- and 10-minute groups, 
the latter intervention group showed a significant reduction 
in fatigue (P < .05) and improvement in role function (P < 
.05) compared with the 2-minute intervention group, 
whereas there were no differences in other outcomes. In a 
comparison between 2 and 20 minutes, anxiety (P < .05), 
fatigue (P < .05), role function (P = .01), and QOL (P < .05) 
were significantly improved in the 20-minute intervention 
group compared with the 2-minute intervention group. 
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Table 1. Patient Characteristics.a
Variables
Acupuncture Dosage Level (Treatment Time)
P 
Value
≤2 Minutes (n = 35), 
Frequency (%)
10 Minutes (n = 53), 
Frequency (%)
20 Minutes (n = 54), 
Frequency (%)
Age, years (mean ± SD)b 59.2 ± 10.6 57.2 ± 9.7 57.2 ± 11.9 .699
Gender
 Male 7 (20) 12 (23) 10 (19) .867
 Female 28 (80) 41 (77) 44 (81)  
Ethnicity
 Caucasian 29 (83) 37 (79) 45 (88) .031
 Other 6 (17) 10 (21) 6 (12)  
Educational level
 Primary 0 (0) 0 (0) 2 (4) .287
 Secondary 7 (20) 8 (16) 13 (25)  
 Tertiary 28 (80) 43 (84) 37 (71)  
Income level ($AUD)
 <30 000 10 (32) 14 (30) 12 (23) .888
 <30 000 To <60 000 5 (16) 6 (13) 9 (17)  
 <60 000 To <100 000 9 (29) 15 (33) 14 (27)  
 >100 000 7 (23) 11 (24) 17 (33)  
Occupation
 Manager/Professional 13 (39) 23 (47) 23 (45) .181
 Tradesperson 0 (0) 4 (8) 1 (2)  
 Salesperson/Clerk 2 (6) 3 (6) 4 (8)  
 Home duties 2 (6) 6 (12) 6 (12)  
 Retired 12 (36) 9 (18) 17 (33)  
 Unemployed 4 (12) 4 (8) 0 (0)  
Primary cancer diagnosis
 Lung 2 (6) 3 (6) 1 (2) .897
 Prostate 4 (11) 3 (6) 5 (10)  
 Breast 19 (54) 31 (62) 34 (65)  
 Brain 1 (3) 1 (2) 0 (0)  
 Ovary 2 (6) 2 (4) 0 (0)  
 Colorectal 1 (3) 3 (6) 4 (8)  
 Other 6 (17) 7 (14) 8 (15)  
Extent of disease
 Localized 25 (78) 35 (73) 41 (80) .653
 Metastasis 7 (22) 13 (27) 10 (20)  
Time since diagnosis
 <12 Months 21 (60) 27 (54) 38 (73) .172
 >12 Months to 5 
years
13 (37) 17 (34) 11 (21)  
 >5 Years 1 (3) 6 (12) 3 (6)  
Treatment receivedc
 Surgery 28 (78) 40 (76) 42 (78) .951
 Chemotherapy 17 (47) 32 (60) 32 (60) .416
 Radiotherapy 29 (81) 44 (83) 43 (80) .9
 Hormonal therapy 8 (22) 20 (38) 13 (24) .181
 Palliative care 0 (0) 1 (2) 1 (2) .711
 Other 3 (8) 2 (4) 2 (4) .543
aP values (χ2 test) are for comparison among groups allocated for acupuncture treatments (≤2 vs 10 vs 20 minutes).
bOne-way ANOVA test was conducted for comparison of age.
cParticipants received more than 1 anticancer treatment.
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However, there were no differences in any outcomes 
between the 10- and 20-minute intervention groups.
Evaluation of Acupuncture Services
Additional information was collected from participants to 
audit the acupuncture services 6 weeks post–acupuncture 
intervention (Table 4). There were no group differences in 
satisfaction with acupuncture services, perceived efficacy 
of acupuncture, side effects, and willingness to continue 
with acupuncture or to recommend the acupuncture service 
to other cancer patients. More than 95% of participants 
indicated that they were satisfied with the service and would 
recommend acupuncture to other cancer patients, friends, 
and family members. The responses to the query on how 
they perceived the effectiveness of acupuncture were as fol-
lows: effective, 70%; not effective, 29%; and difficult to 
judge, 1%.
Discussion
The importance of needle retention duration on clinical out-
comes was described in early acupuncture classical text-
books “The Systematic Classic of Acupuncture and 
Moxibustion”19 published during the Jin dynasty (265-420 
ce) and “The Great Compendium of Acupuncture and 
Moxibustion”20 published during the Ming dynasty in 1601. 
The authors recommended retention times as brief as 3 
exhalations19 and 6 exhalations20 for certain acupuncture 
points to treat particular medical conditions and manage 
symptoms. Despite multiple studies demonstrating the 
potential benefits of acupuncture over the past 2 decades, 
no trials in Western countries have investigated the associa-
tion between acupuncture needle dosage (needle retention 
duration, frequency, and total acupuncture dose) and clini-
cal outcomes in cancer populations. The current retrospec-
tive study examined the effect of acupuncture needle 
retention duration on clinical outcomes (anxiety, depres-
sion, stress, fatigue, and QOL). The most notable feature of 
the current study is that to our knowledge this is the first 
exploratory study examining the relationship between acu-
puncture needle retention duration and clinical outcomes in 
cancer patients. Moreover, the results of the study provide 
valuable information for use in designing future RCTs with 
acupuncture.
The study found that outcomes were significantly 
improved in all 3 groups 6 weeks postintervention. Most 
outcome measures showed no significant differences 
between the 3 groups (≤2 vs 10 vs 20 minutes); however, 2 
minutes was inferior in terms of fatigue and role function 
when compared with 10 minutes and, additionally, anxiety 
and QOL when compared with 20 minutes. This, combined 
with the lack of significant differences between 10 and 20 
minutes, suggests that the effects of acupuncture on clinical 
outcomes in cancer patients may not depend on the needle 
retention duration once a certain threshold is reached. The 
findings of the present study are in agreement with Hansen’s 
study,29 which examined the effects of acupuncture (5 vs 20 
Table 2. Main Reasons for Considering Acupuncture.a
Variables
Acupuncture Dosage Level (Treatment Time)
P 
Value
<2 Minutes (n = 35), 
Frequency (%)
10 Minutes (n = 53), 
Frequency (%)
20 Minutes (n = 54), 
Frequency (%)
Fatigue 16 (44.4) 27 (50.9) 35 (64.8) .223
Lack of energy 16 (44.4) 18 (34) 27 (50) .197
Improve immune function 6 (16.7) 12 (22.6) 17 (31.5) .396
Pain 11 (30.6) 26 (49.1) 25 (46.3) .112
Difficulty sleeping 14 (38.9) 18 (34) 28 (51.9) .279
Anxiety 5 (13.9) 10 (18.9) 17 (31.5) .050
Neuropathy (tingling in hands and feet etc) 13 (36.1) 14 (26.4) 18 (33.3) .584
Depressed mood 5 (13.9) 10 (18.9) 14 (25.9) .179
Improve quality of life 3 (8.3) 11 (20.8) 12 (22.2) .303
Headaches 2 (5.6) 4 (7.5) 9 (16.7) .300
Nausea 2 (5.6) 8 (15.1) 11 (20.4) .246
Lack of enjoyment of life 1 (2.8) 6 (11.3) 14 (25.9) .035b
Constipation 4 (11.1) 8 (15.1) 10 (18.5) .739
Diarrhea 1 (2.8) 6 (11.3) 11 (20.4) .093
Lack of appetite 0 (0) 5 (9.4) 9 (16.7) .077
Hot flush 10 (27.8) 9 (17) 7 (13) .352
Other reasons 5 (13.9) 8 (15.1) 4 (7.4) .295
aP values (χ2 test) are for comparison among groups allocated for acupuncture treatments (≤2 vs 10 vs 20 minutes).
bP < 0.05.
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minutes) in patients with chronic neck and/or shoulder pain. 
Participants received a 10-week course of acupuncture and 
found no differences in pain improvement between the 
groups at 10-week and 6-month follow-ups. The current 
results are also comparable to recent acupuncture guide-
lines and the results of surveys. A resource specifically 
designed for providing treatment to patients with cancer 
recommended 15 minutes of needle retention duration.30 A 
recent survey assessed the views from patients treated with 
acupuncture in 10 minutes of appointments by an individual 
general practitioner in a National Health Service general 
practice and showed beneficial effects on pain and QOL.31 
Conversely, Lundeberg et al32 used acupuncture treatment 
for patients with chronic head and neck pain and suggested 
that pain improved more in those receiving 30 to 60 minutes 
of acupuncture than 1 to 5 minutes. Issues with this finding 
include study design weaknesses such as the randomization 
of multiple groups (manual acupuncture, superficial acu-
puncture, and low- and high-frequency electroacupuncture) 
during a relatively short intervention period testing several 
outcomes.
The present findings may have applications in optimiz-
ing acupuncture provision in a resource-sensitive public 
health care system. For example, greater use of acupuncture 
services could be achieved with 15-minute appointments, in 
contrast to the usual 30 to 60 minutes. However, the results 
need to be interpreted with caution because they do not rule 
out the possibility that longer needle retention duration may 
be more effective in certain medical conditions. Although 
this study found that there are no major differences in clini-
cal outcomes in relation to needle retention duration, the 
total acupuncture intervention duration (30 minutes per 
week for 6 weeks) in the 3 groups were identical. The first, 
second, and third group received, respectively, 10 minutes 
consultation and 20 minutes acupuncture treatment, 10 
minutes consultation, 10 minutes treatment and additional 
10 minutes bedrest, and 10 minutes consultation, 2 minutes 
treatment, and 18 minutes bedrest. There is a possibility that 
the confounding factors (bedrest and doctor-patient rela-
tionship; lifestyle changes, including diet; and use of other 
complementary therapies) may have partially contributed to 
the positive impact on clinical outcomes in addition to the 
acupuncture needle retention duration. Furthermore, con-
sidering these confounding factors, it is difficult to judge 
the true effect of acupuncture on the outcomes. Another 
limitation of the current study is its retrospective study 
design. Unlike RCTs, the current study did not control for 
potential confounding factors and bias. For example, par-
ticipants were not a homogeneous group, but rather included 
those with diagnoses in multiple cancers and different 
Table 3. Comparison Between 3 Treatment Time Conditions, Showing Change Scores for Patient Outcomes.
Variables
Acupuncture Treatment Time Mann-Whitney U-Tests Comparing Each Pair of Groups Preintervention to 
Postintervention on 
the Combined Sample<2 Minutes 10 Minutes 20 Minutes <2 vs 10 Minutes <2 vs 20 Minutes 10 vs 20 Minutes
Median Change Ua P Value U P Value U P Value Wb P Value
Stress measured by PSS
 Stress 1 2 2 251.5 .39 259 .30 481.5 .69 4.22 <.01c
Anxiety and depression measured by HADS
 Anxiety 0 0.5 1 230.5 .10 223.5 .03c 407.5 .22 1.80 .07
 Depression 1 1.5 1 242.5 .16 307.5 .48 413.5 .25 4.54 <.01c
Fatigue measured by FACT-Fc
 Fatigue 0.5 5 5 212 .03c 187 .02c 459.5 .48 5.10 <.01c
QOL measured by EORTC QLQ-C30c
 Physical function 0 6.67 6.67 298 .81 255.5 .36 412 .43 4.18 <.01c
 Role function 8.33 0 0 205.5 .04c 169 .01c 434 .64 2.12 <.03c
 Cognitive function 0 16.67 0 285.5 .34 324.5 .82 424.5 .22 3.58 <.01c
 Emotional function 0 0 8.33 295.5 .45 301.5 .52 506 .94 3.03 <.01c
 Social function 0 16.67 0 288 .36 295 .42 499 .86 3.93 <.01c
 Global QOL 0 8.33 8.33 281.5 .32 229 .04c 440 .33 3.90 <.01c
Symptoms measured by EORTC QLQ-C30c
 Pain 0 0 16.67 307.5 .59 249 .10 424.5 .22 3.76 <.01c
 Nausea/vomiting 0 0 0 246 .16 269.5 .44 404.5 .31 2.06 <.04c
 Dyspnea 0 0 0 267 .59 266 .43 418 .77 1.94 .05
 Sleeping 0 0 0 293.5 .72 284 .73 414.5 .44 3.16 <.01c
 Appetite 0 0 0 291 .65 278 .56 403 .26 1.04 .30
 Constipation 0 0 0 254 .23 227 .08 452 .84 1.71 .09
 Diarrhea 0 0 0 298.5 .40 282 .18 492 .72 2.20 .03c
Abbreviations: PSS, Perceived Stress Scale; HADS, Hospital Anxiety and Depression Scale; FACT-F, Functional Assessment of Cancer Therapy–Fatigue; QOL, quality of life; 
EORTC QLQ-C30, European Organization for Research and Treatment of Cancer Quality of Life.
aU: Mann-Whitney U-tests were performed to compare between the groups.
bW: Wilcoxon test was used to compare preintervention to postintervention on the combined sample.
cP < 0.05.
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stages of cancer and different treatments (chemotherapy, 
radiation therapy, and hormone therapy). Nonetheless, tak-
ing into account the discussion by Patsopoulos33 on the 
advantages and disadvantages of retrospective study, an 
advantage of the current study is that it represents an evalu-
ation of an intervention in real-life routine practice condi-
tions that can be generalized and applied to similar settings. 
In addition, to compensate for the weaknesses of a retro-
spective study, the researchers collected multiple data 
points (demographic profile and reasons for treatment), 
clinical outcomes (anxiety, depression, stress, fatigue, and 
QOL), and perceived benefits of acupuncture and satisfac-
tion with acupuncture services to minimize the effects of 
bias and confounding factors in the study. Another weak-
ness of this study was that it involved a short-term interven-
tion. Patients were eligible to receive 6 sessions of 
acupuncture once per week, compared with other acupunc-
ture trials, which include 12 weeks of treatment and long-
term follow-up.12,16
Despite these limitations, the central study outcome of 
needle retention duration and efficacy was masked to par-
ticipants. The researcher informed all participants that the 
study was designed to evaluate the effects of acupuncture 
on management of adverse cancer treatment effects and to 
collect feedback about the acupuncture service. To test the 
effect of masking in the trial, data relating to participants’ 
perception of and satisfaction with acupuncture services 
were collected at the end of the intervention in addition to 
multiple clinical outcomes. Data analysis showed that there 
was a balance in participants’ perception and satisfaction 
with acupuncture services among the 3 groups, and this 
demonstrated reliability of the masking effect. This 
Table 4. Evaluation of Acupuncture Services.a
Variables
Acupuncture Dosage Level (Treatment Time)
P 
Value
<2 Minutes (n = 35) 
Frequency (%)
10 Minutes (n = 53) 
Frequency (%)
20 Minutes (n = 54) 
Frequency (%)
Was acupuncture effective?
 Yes 12 (60) 22 (66.7) 27 (79.4) .246
 No 7 (35) 11 (33.3) 7 (20.6)  
 Difficult to judge 1 (5) 0 (0) 0 (0)  
Experienced side effect?
 Yes 1 (5) 4 (12.1) 2 (5.9) .067
 No 14 (70) 26 (78.8) 32 (94.1)  
 Difficult to judge 4 (20) 3 (9.1) 0 (0)  
Satisfied with acupuncture services?
 Highly satisfied 14 (70) 25 (75.8) 27 (79.4) .630
 Satisfied 5 (25) 7 (21.2) 4 (11.8)  
 Partially satisfied 1 (5) 1 (3) 3 (8.8)  
 Not satisfied 0 (0) 0 (0) 0 (0)  
Carry on acupuncture
 Definitely 11 (55) 14 (42.4) 14 (41.2) .749
 Probably 4 (20) 13 (39.4) 11 (32.4)  
 Not sure 5 (25) 5 (15.2) 8 (23.5)  
 Probably not 0 (0) 1 (3) 1 (2.9)  
 Definitely not 0 (0) 0 (0) 0 (0)  
Recommend our acupuncture to other cancer patients
 Definitely 17 (89.5) 26 (78.8) 30 (88.2) .322
 Probably 1 (5.3) 6 (18.2) 4 (11.8)  
 Not sure 1 (5.3) 0 (0) 0 (0)  
 Probably not 0 (0) 1 (3) 0 (0)  
 Definitely not 0 (0) 0 (0) 0 (0)  
Recommend acupuncture to your friend and your family members?
 Definitely 13 (68.4) 25 (75.8) 30 (88.2) .286
 Probably 5 (26.3) 7 (21.2) 4 (11.8)  
 Not sure 1 (5.3) 0 (0) 0 (0)  
 Probably not 0 (0) 1 (3) 0 (0)  
 Definitely not 0 (0) 0 (0) 0 (0)  
aP values (χ2 test) are for comparison among groups allocated for acupuncture treatments (≤2 vs 10 vs 20 minutes).
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suggests that the impact of confounding factors and bias on 
clinical outcomes in this study might not be excessive. 
Nevertheless, further robust RCTs with long-term follow-
up are required prior to making an evidence-based recom-
mendation about appropriate needle retention duration and/
or dosage.
In conclusion, acupuncture has the potential to improve 
the QOL of cancer patients. Efficacy or benefits of acupunc-
ture may not only depend on needle retention duration, but 
may also result from multiple factors associated with clinical 
outcomes. Although the current study does not provide suf-
ficient evidence to establish acupuncture practice guidelines 
for needle retention duration, the findings provide critical 
information for the use of acupuncture in cancer care. Robust 
RCTs are warranted to confirm the findings.
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